Medical Properties Trust (NYSE:MPW) was downgraded by equities researchers at Robert W. Baird from an “outperform” rating to a “neutral” rating in a note issued to investors on Friday, January 5th, Marketbeat Ratings reports. They presently have a $13.00 price target on the real estate investment trust’s stock, down from their prior price target of $15.00. Robert W. Baird’s target price suggests a potential upside of 1.88% from the company’s previous close.
A number of other brokerages have also recently weighed in on MPW. Zacks Investment Research cut Medical Properties Trust from a “buy” rating to a “hold” rating in a research report on Wednesday, November 1st. JPMorgan Chase & Co. upgraded Medical Properties Trust from an “underweight” rating to a “neutral” rating and set a $14.50 target price on the stock in a report on Friday, December 15th. SunTrust Banks restated a “buy” rating and set a $15.00 target price on shares of Medical Properties Trust in a report on Friday, November 3rd. KeyCorp restated a “hold” rating on shares of Medical Properties Trust in a report on Sunday, September 17th. Finally, ValuEngine raised Medical Properties Trust from a “hold” rating to a “buy” rating in a research note on Thursday, November 9th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and five have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $14.30.
Shares of Medical Properties Trust (NYSE MPW) traded down $0.06 during midday trading on Friday, hitting $12.76. The company had a trading volume of 2,015,224 shares, compared to its average volume of 2,290,000. Medical Properties Trust has a 1-year low of $11.90 and a 1-year high of $14.22. The company has a current ratio of 2.55, a quick ratio of 2.55 and a debt-to-equity ratio of 1.26. The company has a market cap of $4,650.00, a PE ratio of 16.79, a price-to-earnings-growth ratio of 1.58 and a beta of 0.96.
Medical Properties Trust (NYSE:MPW) last posted its earnings results on Thursday, November 2nd. The real estate investment trust reported $0.33 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.32 by $0.01. Medical Properties Trust had a return on equity of 7.36% and a net margin of 39.95%. The firm had revenue of $176.60 million during the quarter, compared to analyst estimates of $172.57 million. During the same period in the previous year, the company earned $0.30 EPS. The company’s revenue for the quarter was up 39.5% on a year-over-year basis. analysts predict that Medical Properties Trust will post 1.33 EPS for the current fiscal year.
Hedge funds have recently bought and sold shares of the business. Brown Advisory Inc. grew its stake in Medical Properties Trust by 22.0% in the third quarter. Brown Advisory Inc. now owns 49,784 shares of the real estate investment trust’s stock valued at $653,000 after purchasing an additional 8,968 shares in the last quarter. BlueCrest Capital Management Ltd bought a new position in shares of Medical Properties Trust during the 2nd quarter worth approximately $5,349,000. Systematic Financial Management LP acquired a new stake in Medical Properties Trust during the 2nd quarter worth approximately $29,018,000. Goldman Sachs Group Inc. lifted its holdings in Medical Properties Trust by 26.5% during the 2nd quarter. Goldman Sachs Group Inc. now owns 2,091,500 shares of the real estate investment trust’s stock worth $26,917,000 after purchasing an additional 438,140 shares during the last quarter. Finally, Virginia Retirement Systems ET AL acquired a new stake in Medical Properties Trust during the 3rd quarter worth approximately $386,000. Hedge funds and other institutional investors own 81.20% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This article was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/13/medical-properties-trust-mpw-lowered-to-neutral-at-robert-w-baird.html.
About Medical Properties Trust
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.